These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2957808)

  • 1. Increasing survival of dogs subjected to hemorrhagic shock by administration of fructose 1-6 diphosphate.
    Markov AK; Terry J; White TZ; Didlake RH; Hellems HK
    Surgery; 1987 Sep; 102(3):515-27. PubMed ID: 2957808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible hemorrhagic shock: treatment and cardiac pathophysiology.
    Markov AK; Oglethorpe N; Young DB; Hellems HK
    Circ Shock; 1981; 8(1):9-19. PubMed ID: 7237686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics and metabolic effects of fructose 1-6 diphosphate in ischemia and shock--experimental and clinical observations.
    Markov AK
    Ann Emerg Med; 1986 Dec; 15(12):1470-7. PubMed ID: 3777620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of irreversible hemorrhagic shock in dogs with fructose-1,6 diphosphate and dichloroacetate.
    Granot H; Steiner I
    Circ Shock; 1985; 15(3):163-73. PubMed ID: 3978767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructose-1,6-diphosphate: an agent for treatment of experimental endotoxin shock.
    Markov AK; Turner MD; Oglethorpe N; Neely WA; Hellems HK
    Surgery; 1981 Sep; 90(3):482-8. PubMed ID: 6455765
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat.
    Didlake R; Kirchner KA; Lewin J; Bower JD; Markov A
    Circ Shock; 1985; 16(2):205-12. PubMed ID: 4053295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of ischemic renal injury with fructose 1,6-diphosphate.
    Didlake R; Kirchner KA; Lewin J; Bower JD; Markov AK
    J Surg Res; 1989 Sep; 47(3):220-6. PubMed ID: 2770278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of fructose diphosphate in hypoxic and ischemic states.
    Webb WR
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 2):863-6. PubMed ID: 6238213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of exogenously administered fructose-1,6-diphosphate from ischemia reperfusion damage induced on isolated rat heart.
    Lazzarino G; Tavazzi B; Nuutinen M; Giardina B
    Ital J Biochem; 1989; 38(4):251A-253A. PubMed ID: 2583971
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock.
    Zhang JN; Zhang FM; Ma WS; Forrester T
    Cardiovasc Res; 1988 Dec; 22(12):927-32. PubMed ID: 3256432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fructose-1,6-diphosphate in the treatment of chronic heart failure].
    Sun JP; Zhi G; Yang XS
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):274-6, 314. PubMed ID: 2805965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of alpha-naphthylthiourea-induced pulmonary edema with fructose-1,6-diphosphate.
    Markov AK; Causey AL; Didlake RH; Lemos LB
    Exp Lung Res; 2002 Jun; 28(4):285-99. PubMed ID: 12042031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between fructose 1,6-diphosphate, glucose, or normal saline infusions and species-specific blood exchange transfusions in the treatment of bowel ischemia.
    Sawchuk A; Canal D; Slaughter M; Bearman D; O'Connor T; Grosfeld JL
    Surgery; 1986 Oct; 100(4):665-70. PubMed ID: 3764691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ; Erburu L; Kloner RA
    J Med; 1987; 18(1):43-53. PubMed ID: 3474341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of post-arrest cardiac performance: effect of fructose-1,6-diphosphate in the isolated rabbit heart.
    Merli M; Bergui G; Cattani C; Berti F; Marchetti M
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):175-82. PubMed ID: 2799003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose 1-6 diphosphate prevents intestinal ischemic reperfusion injury and death in rats.
    Sun JX; Farias LA; Markov AK
    Gastroenterology; 1990 Jan; 98(1):117-26. PubMed ID: 2293570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of fructose-1,6-diphosphate in patients with chronic ischemic heart disease. Echocardiographic study].
    Pasotti C; Nicrosini S; Fiori G
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):315-20. PubMed ID: 2640054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fructose 1,6-diphosphate on splanchnic artery occlusion shock in the rat.
    Squadrito F; Sturniolo R; Altavilla D; Campo GM; Trimarchi GR; Scuri R; Caputi AP
    Resuscitation; 1989 Dec; 18(2-3):299-307. PubMed ID: 2555881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved left ventricular function after short-term treatment with fructose-1,6-diphosphate: echocardiographic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy.
    Grandi AM; Muggia C; Barzizza F; Venco A; Finardi G
    Clin Ther; 1988; 10(4):372-80. PubMed ID: 2978875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
    Cohen JE; Atluri P; Taylor MD; Grand TJ; Liao GP; Panlilio CM; Suarez EE; Zentko SE; Hsu VM; Berry MF; Smith MJ; Gardner TJ; Sweeney HL; Woo YJ
    Heart Lung Circ; 2006 Apr; 15(2):119-23. PubMed ID: 16469539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.